NEWSpublisher 2007 :: AngloChinese Investments
SEARCH NEWS
date from:
date to:
company:
search for string:
NEWS SECTIONS
COMPANY GROUPS
TOP NEWS
» 23/07/2009 [Company watch]
China Aoxing Pharmaceutical Corp. Receives Renewal of GMP Certification for Capsule Dosage Form of Pharmaceutical Products
» 15/03/2010 [Industry news]
Recordati S.p.A And Lee Pharmaceutical Announce Partnership For Zanidip(R) In China
» 26/10/2009 [Finance]
China Growth to Remain Fast in Fourth Quarter, Official Says
» 17/08/2009 [Industry news]
Chindex Posts Profit on Product Sales, Health Services
» 07/05/2010 [Industry news]
Hong Kong: Recall of all products manufactured by Quality Pharmaceutical Lab Ltd
COMPANY NEWS back to previous page show list
»26/06/2009 [Industry news]
Skystar Bio-Pharmaceutical Begins Trading on NASDAQ Capital Market

Skystar Bio-Pharmaceutical Co., Ltd., a leading China-based producer and distributor of veterinary medicines, vaccines, microorganisms and feed additives, announced that its common stock will begin trading on the NASDAQ Capital Market under the symbol SKBI, effective at the open of trading today, June 26, 2009.

 
Skystar Bio-Pharmaceutical Co., Ltd., a leading China-based producer and distributor of veterinary medicines, vaccines, microorganisms and feed additives, announced that its common stock will begin trading on the NASDAQ Capital Market under the symbol SKBI, effective at the open of trading today, June 26, 2009. Weibing Lu, Chairman and Chief Executive Officer of Skystar, stated: Our move to NASDAQ is a major milestone achievement for Skystar following the substantial growth that we have delivered in revenue, earnings, production capacity and product development. We believe that the NASDAQ Capital Market provides excellent exposure for companies such as ours in emerging markets. This move underscores our commitment to generating long-term value for our shareholders. Most recently, the company common stock traded on the OTC Bulletin Board under the symbol SKBO. About Skystar Bio-Pharmaceutical Co. Skystar is a China-based developer and distributor of veterinary healthcare and medical care products. Skystar has four product lines (veterinary medicines, microorganisms, vaccines and feed additives) and over 170 products, with over 40 additional products in the developmental stage. Skystar has formed strategic sales distribution networks covering 29 provinces throughout China.

AngloChinese Investments ltd.
Home | Company news | TOP 50 | Events | About us
C&F Bright Solutions ltd.